University of Ioannina
Μοριακός σχεδιασμός, σύνθεση και βιολογική δράση εν δυνάμει αναστολέων πρωτεϊνικών κινασών
Abstract
dc:descriptionProtein kinases, the major signal transducers involved in all signaling pathways of the cell, are known to influence cellular processes by enzymatic protein phosphorylation. In cases, mutations in protein kinase molecules, due to the deregulation of signal transduction pathways, lead to autonomic, uncontrolled cell behavior, ignoring extracellular commands and effectively disrupting the mechanisms that regulate the division, differentiation, cells, as well as the immune response. Many forms of cancer, autoimmune diseases, diabetes, etc., are due to such mutations. Breast cancer, despite advances in early detection and treatment, remains a major cause of death in women. The mammalian cell cycle is induced by a complex interaction between cyclin and cyclin-dependent kinases (CDKs). Dysfunction of this process is one of the causes of breast cancer. At the same time, research has shown that the 4-6-Rb cyclin D-cyclin-dependent kinase (CDK) pathway occurs and plays a critical role in many versions of cancer. Ribociclib is a selective, oral bioavailable inhibitor of CDK4 and CDK6, which was approved by the FDA in March 2017 and has been added as a potential treatment along with other inhibitors against CDK 4/6. The aim of the present work is to increase the activity and selectivity of analogues of Ribociclib through selective modifications, as well as τηthe optimization of the synthetic route.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Brentas, Alexios
- Μπρέντας, Αλέξιος
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/53343